Chemical and Nanotechnology-based Approaches to Build Next-gen Oligonucleotide Therapeutics
Join Aurélie Lacroix, PhD and Leonora Abdullahu, PhD, the 2021/2022 OTS Trainee Reps, as they share about their research and career paths. Speaker: Aurélie Lacroix, PhD, Senior Scientist / MSCA fellow, Sixfold Bioscience Bio [...]
Antisense Oligonucleotide-based Therapies for Inherited Retinal Diseases: From Mutation to Clinical Trial
Speaker: Alex Garanto, PhD Date: March 10, 2022 Time: 11-12 EST Description: The eye is at the forefront of therapeutic development for its unique properties. Local delivery of ASOs to the retina has shown to be well tolerated and safe. During this webinar, Prof. [...]
Meet Your 2022 OTS Trainee Reps
Speaker: Chantal Ferguson, MD, PhD Candidate and Hassan Fakih, PhD Date: February 24, 2022 Time: 11-12 EST Description: The OTS values and encourages the contribution of trainees to the society. The trainee representative to the Board of Directors position was created to give trainees [...]
A Perspective From Industry – A Conversation With Richard S. Geary, Ph.D. Executive Vice President, Chief Development Officer at Ionis Pharmaceuticals
Speaker: Richard S. Geary, Ph.D. Date: February 10, 2022 Time: 11-12 EST Description: The OTS Webinar series is pleased to feature Dr. Richard Geary, the current President Elect, and the Executive Vice President, Chief Development Officer at Ionis Pharmaceuticals. For part of the webinar [...]
A Conversation with OTS President, Prof. David Corey
Speaker: David Corey, Ph.D. Date: January 13, 2022 Time: 11-12 EST Description: Join us for an open discussion on the future of the OTS. Prof. David Corey will share his vision for, and answer questions about the OTS. Hosted by former trainee reps, Ronald [...]
Development of N=1 RNA Therapies in the Netherlands and Europe
After the development of Milasen in the United States, there has been an increase in the development of antisense oligonucleotide therapies for patients with unique mutations.
2021 OTS Annual Meeting Poster Winner Showcase
Date: October 29th, 2021 Time: 7am-9am Pacific/ 10am-12pm Eastern/ 4pm-6pm Central European Time Description: Are you having post-event letdown now that the annual OTS meeting is over? We are too! Join us for this special 2-hour webinar to see presentations by four poster award [...]
Presentations & Networking in a Virtual World
Presenter: Aurélie Lacroix, PhD, Sixfold Bioscience Keith T. Gagnon, Ph.D, Southern Illinois University School of Medicine Date: 25 August 2021 Time: 8am Pacific / 11am Eastern / 5m Central Description: Join us for a presentation of tips & tricks for making the most of [...]
Maximize Your Involvement in the OTS Community
Presenter: Erin M. McConnell, Ph.D.,University of Ottawa Annemieke Aartsma-Rus, PhD, OTS President,Leiden University Medical Center Date: June 24, 2021 Time: 8am Pacific/11am Eastern/5pm Central European Time  Description: Do you study how oligonucleotides can be used as therapeutics? Are you new to the OTS? [...]
How to test for immune activation by your therapeutic oligonucleotide
Presenter: Arthur M. Krieg, MD, Checkmate Pharmaceuticals Date: 19 April 2018 Description: RNA and DNA oligonucleotides with charged backbones commonly cause immune activation, which can be recognized by appropriate in vitro and/or in vivo testing. Eukaryotic innate immune systems have evolved multiple receptors to [...]